Streetbeat News

AONC

American Oncology Network Inc

dtocorp.com

Open

3.41

Mkt cap

161M

Volume

6.7K

High

4.13

P/E Ratio

-1.40

52-wk high

4.13

Low

3.41

Div yield

N/A

52-wk low

1.13

American Oncology Network (AONC) has appointed David Afshar as its new Chief Financial and Operating Officer. This strategic move is expected to strengthen the company's financial and operational capabilities.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:31 pm

U.S. stocks traded mostly higher with the Dow Jones, NASDAQ, and S&P 500 all seeing gains. Macy's Inc. reported better-than-expected earnings and raised its FY24 forecast. MGO Global, Biodexa Pharmaceuticals, and Mangoceuticals saw significant stock price increases, while Greenwave Technology Solutions, American Oncology Network, and LuxUrban Hotels experienced notable declines.

Portfolio Pulse from Avi Kapoor

May 21, 2024 | 6:46 pm

American Oncology Network shares are trading lower after the company announced that it will voluntarily delist from the Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 6:34 pm

American Oncology Network (NASDAQ:AONC) announced its decision to voluntarily delist its Class A common stock and warrants from Nasdaq. The last trading day is expected to be on or about June 7, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 6:32 pm

James Hardie Industries (NYSE:JHX) shares fell 14.3% after reporting worse-than-expected quarterly earnings and sales. JP Morgan downgraded the stock from Overweight to Neutral. Other notable movers include MGO Global (NASDAQ:MGOL) up 194% after Q1 results, and Greenwave Technology Solutions (NASDAQ:GWAV) down 60.5% after reporting a year-over-year decrease in Q1 results.

Portfolio Pulse from Avi Kapoor

May 21, 2024 | 5:36 pm

The article highlights significant intraday movements in health care stocks on Tuesday. Notable gainers include Biodexa Pharmaceuticals (BDRX), Genelux (GNLX), Novo Integrated Sciences (NVOS), Bionomics (BNOX), Xylo Technologies (XYLO), and Accelerate Diagnostics (AXDX). On the losing side, Dare Bioscience (DARE), American Oncology Network (AONC), Akanda (AKAN), Scorpius Holdings (SCPX), Sonoma Pharmaceuticals (SNOA), and GT Biopharma (GTBP) experienced notable declines.

Portfolio Pulse from Benzinga Insights

May 21, 2024 | 4:31 pm

U.S. stocks traded mostly higher with the Dow Jones index gaining around 0.2%. Lowe's Companies Inc reported better-than-expected first-quarter financial results. MGO Global, Biodexa Pharmaceuticals, and Mangoceuticals saw significant stock price increases, while Greenwave Technology Solutions, American Oncology Network, and LuxUrban Hotels experienced notable declines.

Portfolio Pulse from Avi Kapoor

May 21, 2024 | 4:00 pm

American Oncology Network (AONC) reported a Q1 EPS of $(1.22), indicating a loss for the quarter.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:57 pm

American Oncology Network (AONC) reported a 20% increase in Q1 revenue, reaching $364.3 million.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:56 pm

American Oncology Network (AONC) has rescheduled its Q1 2024 financial results announcement to Monday, May 20, 2024, before the market opens. A conference call and live webcast with investors will follow on the next day.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 12:37 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.